Liver cancer, most commonly hepatocellular carcinoma (HCC), spreads to the lungs first in the majority of cases. The lungs account for roughly 40 to 55 percent of all extrahepatic metastases, making them the dominant distant destination by a wide margin. But the full picture is more layered than a single organ answer suggests, because liver cancer also has a strong tendency to invade blood vessels within the liver itself before it ever reaches a distant site, and the pattern of spread shifts depending on whether the liver is cirrhotic, what subtype of cancer is involved, and how advanced the tumor has become.
Vascular Invasion Inside the Liver Often Comes Before Distant Spread
Before liver cancer cells travel to the lungs or anywhere else, they frequently invade the blood vessels running through the liver itself. The portal vein, which carries blood into the liver from the digestive tract, is especially vulnerable. A large pooled analysis of nearly 1,500 patients with hepatoma found that portal vein involvement appeared in about 35 percent of cases, making it the second most common site of spread after the lungs.1PubMed. Primary liver cancer: pattern of metastasis When tumor grows into the portal vein, it forms what is called a tumor thrombus, essentially a plug of cancer cells inside the vessel. This can cause rapid deterioration because it blocks blood flow to healthy liver tissue and raises pressure in the portal system.2PubMed Central. Portal Vein Tumor Thrombus: No Longer a Death Sentence
Less frequently, HCC invades the hepatic veins that drain blood out of the liver, and from there it can extend into the inferior vena cava, the large vein that returns blood to the heart.3PubMed Central. Hepatocellular Carcinoma with Hepatic Vein and Inferior Vena Cava Invasion This vascular invasion is significant because it acts as a highway: once cancer cells are inside the venous blood returning to the heart, the next organ the blood passes through is the lungs. That anatomical reality explains why the lungs are the primary distant target.
Why the Lungs Are the Leading Destination
The lung’s role as the most common extrahepatic metastatic site is well established and consistent across studies spanning decades. One review placed lung metastases at 39.5 to 53.8 percent of all extrahepatic spread from primary liver cancer.4PubMed Central. Lung metastases after liver cancer resection cured by immunotherapy: case report and literature review A separate investigation looking at autopsy and clinical data reported incidence rates as high as 55 percent among patients with extrahepatic metastases.5PubMed Central. Unusual location of metastatic lymph nodes of hepatocellular carcinoma in the mediastinum: Case report
The mechanism is straightforward. Blood leaving the liver through the hepatic veins enters the inferior vena cava, flows into the right side of the heart, and is immediately pumped into the lungs for oxygenation. The lungs contain an enormous network of tiny capillaries where cancer cells can lodge and establish new tumors. This is a passive filtering effect: the lungs are simply the first capillary bed that liver-origin tumor cells encounter after entering the venous circulation. Research into the metastatic microenvironment has shown that the lung tissue itself gets remodeled by signals from the primary tumor, creating conditions that help cancer cells survive and colonize after they arrive.6Clinical and Translational Medicine. HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation
Lung metastases from liver cancer can appear as small round nodules scattered across both lungs, or occasionally as a single mass. They may be discovered on routine follow-up imaging after liver cancer treatment, sometimes before they cause any symptoms. When symptoms do appear, they tend to include persistent cough, shortness of breath, or chest pain, though these can be subtle enough to be attributed to other causes.
Lymph Nodes, Bones, and Adrenal Glands
After the lungs, the next most common sites of spread are lymph nodes, bones, and the adrenal glands. These sites are less frequent individually but together account for a substantial share of extrahepatic disease. One clinical summary of patients with confirmed extrahepatic metastases listed the rates as lymph nodes at about 53 percent, bones at 38 percent, and adrenal glands around 15 percent.5PubMed Central. Unusual location of metastatic lymph nodes of hepatocellular carcinoma in the mediastinum: Case report The earlier pooled analysis of 1,497 patients placed portal lymph nodes specifically at 27 percent.1PubMed. Primary liver cancer: pattern of metastasis
Lymph node involvement follows the liver’s natural drainage pathways. Lymphatic fluid from deep within the liver drains to nodes in the hepatoduodenal ligament, the structure connecting the liver to the upper small intestine. Additional lymphatic channels run alongside the inferior vena cava toward the chest, draining to mediastinal lymph nodes behind the heart. Surface lymphatics on the underside of the liver drain to nodes in the hilum, then to regional nodes, while those on the upper surface can drain upward through the diaphragm.7PubMed Central. Effect of Lymphatic Invasion on Survival and Recurrence After Liver Transplantation in Patients with Hepatocellular Carcinoma and Its Prognostic Significance This explains why involved lymph nodes in HCC tend to appear in the abdomen near the liver, but occasionally show up in the chest as well.
Bone metastases from liver cancer most commonly affect the spine, pelvis, and ribs, and they can cause significant pain, fractures, or elevated blood calcium levels. One hospital study found abnormal levels of the enzyme LDH and calcium in bone metastases from liver cancer.8International Journal of Research and Review. An Overview of LDH, Calcium, and CRP Levels in Bone Metastasis Due to Primary Cancer: Breast, Lung, Thyroid, Prostate, and Liver Cancer at Prof. Dr. I.G.N.G. Ngoerah Hospital in January-March 2024 These lab markers can sometimes flag bone involvement before imaging catches it.
Adrenal metastases are uncommon but noteworthy because the adrenal glands sit directly on top of the kidneys, close to the liver, and receive a rich arterial blood supply. Surgery to remove adrenal metastases from HCC has shown meaningful results in selected patients, with one single-center study reporting five-year survival rates above 40 percent after adrenalectomy.9PubMed Central. Clinical outcomes and prognostic factors after adrenalectomy for adrenal metastasis from hepatocellular carcinoma That is a surprisingly good number for metastatic liver cancer, suggesting that isolated adrenal spread may carry a better prognosis than spread to multiple sites.
Peritoneal Spread and Other Rare Sites
The peritoneum, the membrane lining the abdominal cavity, is an infrequent but recognized destination for liver cancer. Peritoneal dissemination tends to happen in more advanced tumors, particularly those that are poorly differentiated or that have ruptured. Tumors growing on the outer surface of the liver, rather than deep within it, also seem more prone to seeding the peritoneum.10PubMed Central. Extrahepatically growing hepatocellular carcinoma diagnosed after presentation with peritoneal dissemination: a case report When peritoneal spread occurs, it can cause fluid buildup in the abdomen that is difficult to distinguish from the ascites that many liver cancer patients already have from underlying cirrhosis.
Rarer metastatic sites include the brain, skin, and soft tissues. These are unusual enough that they often appear as case reports in the medical literature rather than in large series. Some patients present with a metastasis as the first sign of their liver cancer, which can create diagnostic confusion when the metastatic tumor is found before the primary liver lesion is identified.11PubMed Central. The unusual first sign of presentation of hepatocellular carcinoma: a rare case report
How Cirrhosis Changes the Spread Pattern
Most HCC develops in livers that are already damaged by cirrhosis, whether from hepatitis B, hepatitis C, alcohol use, or metabolic liver disease. The presence of cirrhosis meaningfully changes how the cancer spreads. The pooled data on 1,497 patients found that tumors arising in cirrhotic livers were more likely to invade the portal vein, whereas tumors in non-cirrhotic livers were more likely to spread to regional lymph nodes.1PubMed. Primary liver cancer: pattern of metastasis
This makes anatomical sense. Cirrhosis distorts the liver’s internal architecture, creating abnormal blood flow patterns and increased pressure in the portal venous system. These changes may make the portal vein more accessible to an expanding tumor. In a non-cirrhotic liver, the architecture is more preserved, and the lymphatic system functions more normally, so cancer cells may find lymphatic channels a more available route of escape. For patients and their doctors, this distinction matters practically: the surveillance strategy after liver cancer treatment might emphasize different imaging targets depending on whether cirrhosis is present.
Cirrhosis also complicates treatment once metastases are found. Systemic therapies like sorafenib, the first drug to show a survival benefit in advanced HCC, were tested in patients with relatively preserved liver function despite their cirrhosis.12PubMed Central. Cancer and liver cirrhosis: implications on prognosis and management Patients with more severe cirrhosis may not tolerate the same treatments, which limits options for managing metastatic disease.
Cholangiocarcinoma Spreads Differently
Not all liver cancers are HCC. Intrahepatic cholangiocarcinoma, which arises from the bile ducts within the liver, is the second most common type. Its metastatic behavior is quite different. While HCC is notorious for invading blood vessels, cholangiocarcinoma has a stronger tendency to spread through the lymphatic system. These tumors, regardless of where they sit within the liver, preferentially metastasize first to the lymph nodes in the hepatoduodenal ligament, then to nodes along the aorta, behind the pancreas, or near the common hepatic artery.13ScienceDirect (Surgery). Lymphatic spreading pattern of intrahepatic cholangiocarcinoma Tumors on the left side of the liver or near the hilum can also spread along the lesser curvature of the stomach to the left gastric lymph nodes.
This distinction between HCC and cholangiocarcinoma has real consequences. Surgeons evaluating a patient with intrahepatic cholangiocarcinoma need to sample lymph nodes at the time of surgery to accurately stage the disease, whereas lymph node sampling is less routinely performed in HCC resections. The two cancers also respond to different systemic therapies, so knowing which type of liver cancer you are dealing with shapes the entire treatment plan.
Microvascular Invasion and Predicting Who Will Develop Metastases
One of the strongest predictors of whether an HCC will eventually spread is something that can only be confirmed by examining the tumor tissue under a microscope: microvascular invasion. This means cancer cells have penetrated the tiny blood vessels around the tumor, even if they have not yet reached a major vein. Imaging signs that suggest microvascular invasion include an irregular tumor margin, disruption of the tumor capsule, enhancement of the tissue immediately surrounding the tumor on contrast-enhanced scans, multiple tumor nodules, and larger tumor size.14PubMed Central. Microvascular invasion in hepatocellular carcinoma
Patients whose resected tumors show microvascular invasion have significantly higher rates of recurrence and metastasis than those without it. This is why pathologists report microvascular invasion status after every liver cancer surgery, and why some treatment guidelines use it to decide whether additional therapy is warranted after an operation. Before surgery, radiologists look carefully for the imaging clues listed above, because if microvascular invasion is suspected, the surgical team may choose a wider margin of resection or consider alternative treatments.
How Metastases Are Found
Detecting metastases early matters because it changes treatment decisions. Patients with disease confined to the liver may be candidates for surgery, transplant, or ablation, while those with distant spread generally move to systemic therapy. Standard imaging after a liver cancer diagnosis includes CT scans of the chest, abdomen, and pelvis, plus bone scans when bone metastasis is suspected.
PET/CT scanning, which detects increased metabolic activity in cancer cells, has become an increasingly useful tool for staging HCC. A study evaluating a dual-tracer PET/CT approach found sensitivity of 98 percent and accuracy of 96 percent for detecting HCC metastases.15Journal of Nuclear Medicine. Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma HCC is somewhat unusual among cancers in that standard PET scans using a single tracer can miss well-differentiated tumors because they metabolize glucose at rates closer to normal liver tissue. The dual-tracer technique compensates for this blind spot.
For patients who have already been treated for liver cancer, surveillance imaging typically continues at regular intervals for years. Lung metastases are most often caught on routine chest CT, sometimes when they are still too small to cause symptoms. Elevated levels of alpha-fetoprotein in blood tests, a tumor marker commonly tracked in HCC, can also signal recurrence or metastatic disease, though it is not reliable enough to use alone.
When the Liver Is the Metastatic Target Rather Than the Source
An important distinction that can cause confusion: the liver itself is one of the most common destinations for cancer that starts somewhere else, particularly from colorectal cancer.16Journal of Hepatology. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis Metastatic cancer in the liver, sometimes called secondary liver cancer, is far more common than primary liver cancer in many Western countries. When a doctor says someone has “liver metastases,” they usually mean cancer from another organ that has spread to the liver, not cancer that started in the liver. The biology, treatment, and spread patterns of secondary liver cancer are entirely different from those of HCC or cholangiocarcinoma, and the two should not be confused.
For primary liver cancer specifically, the direction of concern is outward: from the liver to the lungs, lymph nodes, bones, and adrenals. The treatment and prognosis are dictated by how far that outward spread has gone, whether the underlying liver function can support treatment, and whether the metastatic deposits are few enough and accessible enough to be treated directly.